SCHEMBL6979537

SCHEMBL6979537

COC(=O)c1ccc(NS(=O)(=O)c2ccc(F)cc2)cc1Cl

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B3 P37058 1/20 0.64
HSD17B2 P37059 1/20 0.64
ALDH1A1 P00352 7/20 0.57
LMNA P02545 4/20 0.57
GAA P10253 1/20 0.57
L3MBTL1 Q9Y468 1/20 0.57
HPGD P15428 2/20 0.53
POLB P06746 1/20 0.52
MEN1 O00255 3/20 0.51
KMT2A Q03164 3/20 0.51
PKM P14618 2/20 0.51
FLT1 P17948 1/20 0.51
FLT4 P35916 1/20 0.51
KDR P35968 1/20 0.51
TSHR P16473 1/20 0.51
NPSR1 Q6W5P4 1/20 0.51
GPR27 Q9NS67 3/20 0.50
MAPT P10636 2/20 0.50
AVPR2 P30518 1/20 0.50
KDM4E B2RXH2 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6976969 0.92 LMNA (0.57) HSD17B3HSD17B2ALDH1A1LMNAGAA
SCHEMBL7146905 0.86 ALDH1A1 (0.57) HSD17B3HSD17B2ALDH1A1LMNAGAA
SCHEMBL6979802 0.85 LMNA (0.60) HSD17B3HSD17B2ALDH1A1LMNAGAA
SCHEMBL1016778 0.79 POLB (0.55) ALDH1A1LMNAGAAL3MBTL1HPGD
SCHEMBL15055007 0.78 ALDH1A1 (0.59) HSD17B3HSD17B2ALDH1A1LMNAGAA
SCHEMBL6977966 0.78 MAPT (0.70) ALDH1A1LMNAGAAHPGDPOLB
SCHEMBL15772389 0.78 MAPT (0.70) ALDH1A1LMNAGAAHPGDPOLB
SCHEMBL15056080 0.78 ALDH1A1 (0.55) ALDH1A1LMNAGAAL3MBTL1HPGD
SCHEMBL17340511 0.77 ALDH1A1 (0.63) ALDH1A1LMNAGAAL3MBTL1POLB
SCHEMBL164411 0.77 HPGD (0.53) ALDH1A1L3MBTL1HPGDKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1109560-B1 COMPOUNDS USEFUL AS AICARFT INHIBITORS AGOURON PHARMA (US) 2003-08-27 EP disclosed
US-6525050-B1 Inhibit the enzyme aminoimidazole carboxamide ribonucleotide formyl transferase; antiproliferative agents; antitumor, antiinflammatory, antipsoriatic, and/or immunosuppressive AGOURON PHARMACEUTICALS, INC. 2003-02-25 US disclosed
EP-1109560-A4 COMPOUNDS USEFUL AS AICARFT INHIBITORS AGOURON PHARMA (US) 2002-04-17 EP disclosed
EP-1109560-A1 COMPOUNDS USEFUL AS AICARFT INHIBITORS AGOURON PHARMACEUTICALS, INC. (US) 2001-06-27 EP disclosed
WO-2000013688-A1 COMPOUNDS USEFUL AS AICARFT INHIBITORS AGOURON PHARMACEUTICALS, INC. (US) 2000-03-16 WO disclosed